List of bibliographic references
Number of relevant bibliographic references: 55.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000009 (2008) |
Misato Hashizume [Japon] ; Masahiko Mihara [Japon] | Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling |
000015 (2013) |
Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne] | Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice |
000038 (2016) |
Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France] | Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study |
000041 (2014) |
P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni] | A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab |
000058 (2014) |
Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel | Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance |
000067 (2010) |
R. Yoshiki [Japon] ; M. Nakamura [Japon] ; Y. Tokura [Japon] | Drug eruption induced by IL‐6 receptor inhibitor tocilizumab |
000095 (2009) |
Paul Emery ; Rhonda Siddall | Tocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis |
000142 (2010) |
| Deal watch: BMS acquires rights for IL-6 inhibitor |
000249 (2010) |
R. E. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne] | Biologika in Schwangerschaft und Stillzeit |
000265 (2009) |
Margaret Hy [Royaume-Uni] ; Ernest Hs Choy [Royaume-Uni] | Certolizumab pegol: a new option for rheumatoid arthritis |
000306 (2013) |
Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque] | Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry |
000323 (2013) |
P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie] | Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature |
000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
000331 (2012) |
Yoshikuni Mimata [Japon] ; Akihisa Kamataki ; Shinya Oikawa [Japon] ; Kenya Murakami [Japon] ; Miwa Uzuki ; Tadashi Shimamura [Japon] ; Takashi Sawai | Interleukin‐6 upregulates expression of ADAMTS‐4 in fibroblast‐like synoviocytes from patients with rheumatoid arthritis |
000343 (2007) |
Norihiro Nishimoto [Japon] ; Jun Hashimoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Norikazu Murata [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Tadamitsu Kishimoto [Japon] | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab |
000458 (2013) |
A. Watik [Maroc] ; W. Rachidi [Maroc] ; S. Janani [Maroc] ; O. Mkinsi [Maroc] | AB0300 Efficacy of rituximab in the treatment of rheumatoid arthritis in moroccan patients tnf alpha inhibitor-naive: a prospective study |
000466 (2009) |
Taio Naniwa [Japon] ; Maiko Watanabe [Japon] ; Shogo Banno [Japon] ; Tomoyo Maeda [Japon] | Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies |
000529 (2013) |
J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni] | AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study |
000617 (2013) |
E. V. Tchetina ; K. H. Kuzikyants ; A. Y. Devyataikina ; G. V. Lukina ; E. L. Nasonov [Russie] | AB0529 Rituximab therapy monitoring by mtor, autophagy-related ULK1, caspase 3, CDK-inhibitor P21, TNF alpha, and osteoclast-specific cathepsin K and gelatinase MMP-9 gene expression in the peripheral blood of rheumatoid arthritis patients |
000629 (2013) |
J. Nakagawa ; Y. Koyama ; T. Horiuchi [Japon] ; A. Uchino ; T. Ota ; S. Nagano | FRI0188 IL-6 inhibitor or TNF inhibitor? A scoring method to predicts preferable treatment for rheumatoid arthritis |
000713 (2011) |
M. Korppi [Finlande] ; Me Van Gijn [Pays-Bas] ; K. Antila [Finlande] | Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inhibitor"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i \
-Sk "inhibitor" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Istex
|étape= Curation
|type= indexItem
|index= AbsEn.i
|clé= inhibitor
}}
| This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 | |